As of April 2, 2026, the CDC reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—kindergarten rates fell to 92.5% in the 2024–2025 school year, below the 95% herd immunity threshold. Nearly all cases (92%) occurred in unvaccinated or unknown-status individuals, fueled by international travel imports and sustained community transmission in under-vaccinated pockets. Hospitalizations stand at 5%, with no deaths. Weekly CDC updates (typically Thursdays) and school-year vaccination drives will shape trajectories; warmer months may slow spread, but spring travel risks persist, leaving year-end totals uncertain based on containment success.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · AktualisiertMasernfälle in den USA im Jahr 2026?
Masernfälle in den USA im Jahr 2026?
$7,502,074 Vol.
$7,502,074 Vol.
31. Dez. 2026
↑2k
99%
↑3k
89%
↑4k
68%
↑5k
49%
↑7,5k
22%
↑10k
13%
↑12,5k
11%
$7,502,074 Vol.
$7,502,074 Vol.
31. Dez. 2026
↑2k
$36,031 Vol.
99%
↑3k
$27,682 Vol.
89%
↑4k
$131,712 Vol.
68%
↑5k
$187,699 Vol.
49%
↑7,5k
$153,681 Vol.
22%
↑10k
$6,474,147 Vol.
13%
↑12,5k
$316,358 Vol.
11%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 2, 2026, the CDC reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—kindergarten rates fell to 92.5% in the 2024–2025 school year, below the 95% herd immunity threshold. Nearly all cases (92%) occurred in unvaccinated or unknown-status individuals, fueled by international travel imports and sustained community transmission in under-vaccinated pockets. Hospitalizations stand at 5%, with no deaths. Weekly CDC updates (typically Thursdays) and school-year vaccination drives will shape trajectories; warmer months may slow spread, but spring travel risks persist, leaving year-end totals uncertain based on containment success.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Dec 1, 2025, 12:56 PM ET
Volumen
$7,502,074Enddatum
31. Dez. 2026Markt eröffnet
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 2, 2026, the CDC reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—kindergarten rates fell to 92.5% in the 2024–2025 school year, below the 95% herd immunity threshold. Nearly all cases (92%) occurred in unvaccinated or unknown-status individuals, fueled by international travel imports and sustained community transmission in under-vaccinated pockets. Hospitalizations stand at 5%, with no deaths. Weekly CDC updates (typically Thursdays) and school-year vaccination drives will shape trajectories; warmer months may slow spread, but spring travel risks persist, leaving year-end totals uncertain based on containment success.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,502,074Enddatum
31. Dez. 2026Markt eröffnet
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of April 2, 2026, the CDC reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—kindergarten rates fell to 92.5% in the 2024–2025 school year, below the 95% herd immunity threshold. Nearly all cases (92%) occurred in unvaccinated or unknown-status individuals, fueled by international travel imports and sustained community transmission in under-vaccinated pockets. Hospitalizations stand at 5%, with no deaths. Weekly CDC updates (typically Thursdays) and school-year vaccination drives will shape trajectories; warmer months may slow spread, but spring travel risks persist, leaving year-end totals uncertain based on containment success.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen